The effect of RAAS blockade on the progression of diabetic nephropathy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of RAAS blockade on the progression of diabetic nephropathy
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 10, Issue 2, Pages 77-87
Publisher
Springer Nature
Online
2013-12-03
DOI
10.1038/nrneph.2013.251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- Hypotension and ischaemic stroke associated with aliskiren in the ALTITUDE trial: Sensitisation of the Bezold–Jarisch reflex?
- (2013) Peter Sever JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Dual RAS blockade—controversy resolved
- (2013) Piero Ruggenenti et al. Nature Reviews Nephrology
- Evidence of the syndrome of rapid onset end-stage renal disease (SORO-ESRD) in the acute kidney injury (AKI) literature – preventable causes of AKI and SORO-ESRD – a call for re-engineering of nephrology practice paradigms
- (2013) Macaulay A.C. Onuigbo RENAL FAILURE
- US Renal Data System 2012 Annual Data Report
- (2012) Allan J. Collins et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
- (2012) D. Di Raimondo et al. CURRENT PHARMACEUTICAL DESIGN
- SM-368229, a Novel Promising Mineralocorticoid Receptor Antagonist, Shows Antihypertensive Efficacy With Minimal Effect on Serum Potassium Level in Rats
- (2012) Tetsuro Nariai et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers
- (2012) Hiddo J. Lambers Heerspink et al. KIDNEY INTERNATIONAL
- Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy
- (2012) Sara S. Roscioni et al. Nature Reviews Nephrology
- Improving the efficacy of RAAS blockade in patients with chronic kidney disease
- (2012) Hiddo J. Lambers Heerspink et al. Nature Reviews Nephrology
- Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases
- (2012) E. Morales et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- ACE2, angiotensin-(1–7), and Mas: the other side of the coin
- (2012) Michael Bader PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Notice
- (2012) Kidney International Supplements
- Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension
- (2011) David A. Calhoun et al. CIRCULATION
- Aliskiren in Combination with Losartan Reduces Albuminuria Independent of Baseline Blood Pressure in Patients with Type 2 Diabetes and Nephropathy
- (2011) F. Persson et al. Clinical Journal of the American Society of Nephrology
- Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
- (2011) Femke Waanders et al. Current Vascular Pharmacology
- Initial Angiotensin Receptor Blockade-Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial
- (2011) M. E. Hellemons et al. DIABETES CARE
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
- (2011) E. Imai et al. DIABETOLOGIA
- Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
- (2011) B. Pitt et al. EUROPEAN HEART JOURNAL
- Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment
- (2011) Yan Miao et al. HYPERTENSION
- SM-368229, a Novel Selective and Potent Non-steroidal Mineralocorticoid Receptor Antagonist With Strong Urinary Na+ Excretion Activity
- (2011) Tetsuro Nariai et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aldosterone and inflammation
- (2011) Kimberly C Gilbert et al. Current Opinion in Endocrinology Diabetes and Obesity
- Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
- (2010) Helmy M. Siragy et al. AMERICAN JOURNAL OF NEPHROLOGY
- Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
- (2010) Y. Miao et al. DIABETOLOGIA
- Aldosterone Synthase Inhibition With LCI699
- (2010) Laurence Amar et al. HYPERTENSION
- The RAAS in the pathogenesis and treatment of diabetic nephropathy
- (2010) Piero Ruggenenti et al. Nature Reviews Nephrology
- Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function
- (2010) M. C. J. Slagman et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Systolic Heart Failure
- (2010) John J.V. McMurray NEW ENGLAND JOURNAL OF MEDICINE
- Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD
- (2010) Macaulay A.C. Onuigbo RENAL FAILURE
- Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
- (2009) L. F. Fried et al. Clinical Journal of the American Society of Nephrology
- Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
- (2009) F. Persson et al. DIABETES CARE
- Dual Renin-Angiotensin System Blockade and Kidney Disease
- (2009) Hans-Henrik Parving et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Biology of the (Pro)Renin Receptor
- (2009) G. Nguyen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt
- (2009) William B. Lea et al. KIDNEY INTERNATIONAL
- In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
- (2009) Bruce A. Perkins et al. KIDNEY INTERNATIONAL
- Radiographic Contrast-Induced Nephropathy and Patient Mortality–2
- (2009) Macaulay A.C. Onuigbo MAYO CLINIC PROCEEDINGS
- Is the ONTARGET renal substudy actually off target?
- (2009) Piero Ruggenenti et al. Nature Reviews Nephrology
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
- (2009) Michael Mauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
- (2008) M. F. Lopes-Virella et al. DIABETES CARE
- Diabetic Nephropathy: Mechanisms of Renal Disease Progression
- (2008) Yashpal S. Kanwar et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
- (2008) L. Vogt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes
- (2008) F. Persson et al. KIDNEY INTERNATIONAL
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis
- (2008) M.A.C. Onuigbo et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes
- (2007) A. Mohanram et al. KIDNEY INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started